Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico…
Clinical
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Acquisitions
X-Vax Technology Appoints Isaac Blech as Vice Chairman to its Board…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Clinical
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Clinical
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement…
Clinical
Medicine Supply Notification: Ketotifen 1mg/5ml elixir (Zaditen) – FirstWord Pharma
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Sanofi eyes acquisitions in US, including Principia Biopharma: report – FirstWord…
Clinical
Lilly’s mirikizumab superior to Novartis’ Cosentyx in psoriasis study – FirstWord…
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Clinical
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Home
Therapy areas
Immuno-inflammation
Immuno-inflammation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-inflammation
Johnson & Johnson reports positive results for Stelara using “treat-to-target” approach in Phase III Crohn’s disease trial
Firstwordpharma News
-
February 14, 2020
Immuno-inflammation
Physician Views snap poll: AbbVie builds out clinical case for Rinvoq in psoriatic arthritis; how do rheumatologists perceive the data?
Immuno-inflammation
AbbVie’s SKYRIZI Now Publicly Reimbursed in Ontario, Alberta, Saskatchewan and Quebec for the Treatment of Moderate to Severe Plaque Psoriasis
Immuno-inflammation
Atlantic Healthcare Hosts Key Opinion Leader Discussion on Unmet Medical Need in Ulcerative Colitis and the Advantages of Alicaforsen
Immuno-inflammation
Penn Researchers Identify Cancer Cell Defect Driving Resistance to CAR T Cell Therapy
Immuno-inflammation
Discovery would allow researchers to fine-tune CAR-T activity
Firstwordpharma News
-
January 30, 2020
0
Immuno-inflammation
Hansa Biopharma Completes Enrollment in Anti-GBM
Biospace News
-
January 27, 2020
0
Immuno-inflammation
Drug profiling and gene scissors open new avenues in immunotherapy
Firstwordpharma News
-
January 22, 2020
0
Immuno-inflammation
ICER Issues Final Report and Policy Recommendations on JAK Inhibitors for...
Firstwordpharma News
-
January 9, 2020
0
Immuno-inflammation
Durect Drug Fails to Shine in Mid-Stage Plaque Psoriasis Trial
Biospace News
-
January 3, 2020
0
1
2
3
...
7
Page 1 of 7
- Advertisement -
MOST POPULAR
Poll Takers Place Opioid Crisis Blame at the Feet of the...
April 26, 2019
Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III...
March 19, 2019
One-Year Results from Positive Phase 3 EYLEA Trial in Diabetic Retinopathy...
February 10, 2019
Lilly to Participate in New Model Designed to Make Insulins More...
March 11, 2020
Load more
HOT NEWS
In vivo
Mallinckrodt Reports Top-Line Results from Proof-of-Concept Study of Nitric Oxide Gas...
Commercial
PDS Biotechnology Accepted for Oral Presentation at the 34th Annual Society...
Commercial
Oncopeptides Strengthens its Regulatory Function by Appointing Karin Eklund Vanderpol as...
Others
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) –...
